Skip to main content
oAv Menu
Home
Patient Care Center
Clinical Trials
Providers
Therapeutics
People
Places
Community Center
Community Stories
Social Media
Community Content
Financial Assistance
News
Community Events
Clinical Trials and Research
Business
News People
Happenings
Spotlight
Fundraising Events
Trusted Resources
Education
Videos & Visuals
Event Calendar
Login
Search
UPCOMING SESSIONS
in
ET
Thu, Apr 30, 2026
10:00 – 11:00 PM UTC
Amyloidosis In The Home: Transforming Stress Into Strength Within Your Relationships
Nick Propper
Click To Register
View all
UPCOMING SESSIONS
in
ET
Thu, Apr 30, 2026 · 10:00 – 11:00 PM UTC
Amyloidosis In The Home: Transforming Stress Into Strength Within Your Relationships
Nick Propper
Click To Register
View all sessions
All Upcoming Sessions
3
APR
30
Amyloidosis In The Home: Transforming Stress Into Strength Within Your Relationships
Thu, Apr 30, 2026 · 10:00 – 11:00 PM UTC
Nick Propper
Register
MAY
4
Stressed Self to Best Self: The Science-Backed System for Sustainable Peak Performance
Mon, May 4, 2026 · 10:00 – 11:00 PM UTC
Register
MAY
6
Emerging Roles of TTR in ATTR-CM and Your Overall Health
Wed, May 6, 2026 · 10:00 – 11:00 PM UTC
Sarah C Paciulli
Register
Long-Term Durability of Acoramidis Efficacy in Transthyretin Amyloid Cardiomyopathy Open-Label Extension of the ATTRibute-CM Randomized Clinical Trial
Mar 30, 2026
News
FDA Grants Fast Track to Coramitug for ATTR-CM, Supporting Amyloid-Clearing Phase 3 Trial
Apr 28, 2026
EPIC-ATTR: A Study to Evaluate the Effect of Eplontersen on the Transthyretin Reduction and Long-term Safety in Chinese Subjects With Transthyretin Amyloid Cardiomyopathy
Apr 28, 2026
Quantitative imaging in cardiac transthyretin amyloidosis: rationale and design of the i-CARE study
Apr 28, 2026
Prothena Announces Novo Nordisk Obtains Fast Track Designation from the U.S. FDA for Coramitug (PRX004) in ATTR Amyloidosis with Cardiomyopathy
Apr 27, 2026
Prothena Announces Novo Nordisk Obtains Fast Track Designation from the U.S. FDA for Coramitug (PRX004) in ATTR Amyloidosis with Cardiomyopathy
Apr 27, 2026
More in News
Education
The Cardiac Amyloidosis Revolution: How ATTR Therapies Are Rewriting Heart Failure Treatment in 2026
Apr 18, 2026
ACC CardiaCast: ATTR-CM Treatment: Recent Updates
Apr 17, 2026
How ATTR amyloidosis can progress over time
Apr 15, 2026
Real-world Experience with Tafamidis in patients with Cardiac Amyloidosis
Apr 15, 2026
The Future of ATTR-CM Treatment
Apr 15, 2026
More in Education
Community Center
National Ataxia Foundation
Apr 16, 2026
Amyloidosis Support Group Meeting
Apr 15, 2026
Cardiac Amyloidosis: A Hidden Cause of Heart Failure Is Now Treatable
Apr 15, 2026
Amyloidosis Awareness
Apr 14, 2026
Amyloidosis Awareness
Apr 14, 2026
More in Community Center
Video
